No Picture
News

Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update

MARINA DEL REY, Calif., Aug. 14, 2019 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resi… […]

No Picture
News

Selections from DISORDER: The Rare Disease Film Festival to show during Biotech Week Boston this September

CARLSBAD, Calif. and BOSTON, Aug. 8, 2019 /PRNewswire/ — The second annual Selections from DISORDER: The Rare Disease Film Festival at Biotech Week Boston will be held at the Takeda Auditorium in Cambridge, MA, on September 12 from… […]

No Picture
News

Roche to showcase how health networks are driving change through innovation in the lab and beyond at AACC 2019 Clinical Lab Expo

– Featured health networks improve patient care through innovative technologies and optimizing operations- Digital tools harness rich data streams to provide clinical decision support, patient insights and improved operational effectiveness

INDIANAPO… […]

No Picture
News

Mesa Biotech to Present Comparative Flu & RSV Detection Analysis with Other FDA-Cleared Molecular Assays at the AACC Annual Scientific Meeting Lecture Series

Lecture Will Provide a Technology Overview and Performance Characteristics of Accula(TM), Sample-to-answer, CLIA-waived PCR System

SAN DIEGO, July 31, 2019 /PRNewswire/ — Mesa Biotech Inc. is a privately-held, molecular diagnostic company that h… […]

No Picture
News

Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting

RSV Test Represents Expansion of FDA Cleared, CLIA-Waived and CE Marked PCR Point-of-care Testing Portfolio

SAN DIEGO, July 29, 2019 /PRNewswire/ — Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, s… […]

No Picture
News

Armata Pharmaceuticals to Host Key Opinion Leader Meeting on Bacteriophage-Based Therapeutics on June 26 in New York

MARINA DEL REY, Calif., June 18, 2019 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today anno… […]